Invasion of burkholderia cepacia complex isolates into lung epithelial cells involves glycolipid receptors

Microbial Pathogenesis

Volumn 49, Issue 6, 2010, Pages 381-387

  Mullen, Tracy ^a   Callaghan, Máire ^a   McClean, Siobhán ^a  

^a DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

Author keywords

Bacterial adherence; Bacterial invasion; Burkholderia cepacia complex; Cystic fibrosis; Glycosphingolipids; Lung epithelial cells

Indexed keywords

ALPHA GALACTOSIDASE; BETA GALACTOSIDASE; GLYCOLIPID RECEPTOR; MUCIN; UNCLASSIFIED DRUG;

ARTICLE; BACTERIUM ADHERENCE; BIOTINYLATION; BURKHOLDERIA; BURKHOLDERIA CENOCEPACIA; BURKHOLDERIA CEPACIA COMPLEX; BURKHOLDERIA MULTIVORANS; CELL INVASION; CONTROLLED STUDY; CYSTIC FIBROSIS; LIPOGENESIS; LUNG ALVEOLUS EPITHELIUM; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; STRAIN DIFFERENCE; THIN LAYER CHROMATOGRAPHY;

ALPHA-GALACTOSIDASE; BACTERIAL ADHESION; BETA-GALACTOSIDASE; BURKHOLDERIA CEPACIA COMPLEX; CELL LINE; EPITHELIAL CELLS; GLYCOSPHINGOLIPIDS; HUMANS; RECEPTORS, CELL SURFACE;

BACTERIA (MICROORGANISMS); BURKHOLDERIA CENOCEPACIA; BURKHOLDERIA CEPACIA COMPLEX; BURKHOLDERIA MULTIVORANS;

EID: 77957779236     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2010.08.003     Document Type: Article

References (32)

1. Mahenthiralingam E., Coenye T., Chung J.W., Speert D.P., Govan J.R., Taylor P., et al. Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex. J Clin Microbiol 2000, 38:910-913.
2. Coenye T., Vandamme P., LiPuma J.J., Govan J.R., Mahenthiralingam E. Updated version of the Burkholderia cepacia complex experimental strain panel. J Clin Microbiol 2003, 41:2797-2798.
3. Jones A.M., Dodd M.E., Govan J.R., Barcus V., Doherty C.J., Morris J., et al. Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis. Thorax 2004, 59:948-951.
4. Baldwin A., Mahenthiralingam E., Drevinek P., Pope C., Waine D.J., Henry D.A., et al. Elucidating Global Epidemiology of Burkholderia multivorans in cases of cystic fibrosis by Multilocus sequence Typing. J Clin Microbiol 2008, 46:290-295.
5. Reik R., Spilker T., Lipuma J.J. Distribution of Burkholderia cepacia complex species among isolates recovered from persons with or without cystic fibrosis. J Clin Microbiol 2005, 43:2926-2928.
6. Cieri M.V., Mayer-Hamblett N., Griffith A., Burns J.L. Correlation between an in vitro invasion assay and a murine model of Burkholderia cepacia lung infection. Infect Immun 2002, 70:1081-1086.
7. Duff C., Murphy P.G., Callaghan M., McClean S. Differences in invasion and translocation of Burkholderia cepacia complex species in polarised lung epithelial cells in vitro. Microb Pathog 2006, 41:183-192.
8. McClean S., Callaghan M. Burkholderia cepacia complex: epithelial cell-pathogen confrontations and potential for therapeutic intervention. J Med Microbiol 2009, 58:1-12.
9. Sajjan U.S., Corey M., Karmali M.A., Forstner J.F. Binding of Pseudomonas cepacia to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis. J Clin Invest 1992, 89:648-656.
10. Urban T.A., Goldberg J.B., Forstner J.F., Sajjan U.S. Cable pili and the 22-kilodalton adhesin are required for Burkholderia cenocepacia binding to and transmigration across the squamous epithelium. Infect Immun 2005, 73:5426-5437.
11. Sajjan S.U., Forstner J.F. Identification of the mucin-binding adhesin of Pseudomonas cepacia isolated from patients with cystic fibrosis. Infect Immun 1992, 60:1434-1440.
12. Sajjan U., Ackerley C., Forstner J. Interaction of cblA/adhesin-positive Burkholderia cepacia with squamous epithelium. Cell Microbiol 2002, 4:73-86.
13. Sajjan U.S., Hershenson M.B., Forstner J.F., Lipuma J.J. Burkholderia cenocepacia ET12 strain activates TNFR1 signalling in cystic fibrosis airway epithelial cells. Cell Microbiol 2007.
14. Schengrund C.L. "Multivalent" saccharides: development of new approaches for inhibiting the effects of glycosphingolipid-binding pathogens. Biochem Pharmacol 2003, 65:699-707.
15. Hanada K. Sphingolipids in infectious diseases. Jpn J Infect Dis 2005, 58:131-148.
16. Sylvester F.A., Sajjan U.S., Forstner J.F. Burkholderia (Basonym Pseudomonas) cepacia binding to lipid receptors. Infect Immun 1996, 64:1420-1425.
17. Krivan H.C., Roberts D.D., Ginsburg V. Many pulmonary pathogenic bacteria bind specifically to the carbohydrate sequence GalNAc beta 1-4 Gal found in some glycolipids. Proc Natl Acad Sci U S A 1988, 85:6157-6161.
18. Merrill A.H., van Echten G., Wang E., Sandhoff K. Fumonisin B1 inhibits sphingosine (sphinganine) N-acyltransferase and de novo sphingolipid biosynthesis in cultured neurons in situ. J Biol Chem 1993, 268:27299-27306.
19. Ratner L., vander Heyden N., Dedera D. Inhibition of HIV and SIV infectivity by blockade of alpha-glucosidase activity. Virology 1991, 181:180-192.
20. Martin D.W., Mohr C.D. Invasion and intracellular survival of Burkholderia cepacia. Infect Immun 2000, 68:24-29.
21. Caraher E., Duff C., Mullen T., Mc Keon S., Murphy P., Callaghan M., et al. Invasion and biofilm formation of Burkholderia dolosa is comparable with Burkholderia cenocepacia and Burkholderia multivorans. J Cyst Fibros 2007, 6:49-56.
22. Huang X.Z., Tall B., Schwan W.R., Kopecko D.J. Physical limitations on Salmonella typhi entry into cultured human intestinal epithelial cells. Infect Immun 1998, 66:2928-2937.
23. van Ham S.M., van Alphen L., Mooi F.R., van Putten J.P. Contribution of the major and minor subunits to fimbria-mediated adherence of Haemophilus influenzae to human epithelial cells and erythrocytes. Infect Immun 1995, 63:4883-4889.
24. Shuter J., Hatcher V.B., Lowy F.D. Staphylococcus aureus binding to human nasal mucin. Infect Immun 1996, 64:310-318.
25. Aristoteli L.P., Willcox M.D. Adhesion of Pseudomonas aeruginosa ocular isolates to mucin. Clin Exp Ophthalmol 2001, 29:143-146.
26. Krivan H.C., Ginsburg V., Roberts D.D. Pseudomonas aeruginosa and Pseudomonas cepacia isolated from cystic fibrosis patients bind specifically to gangliotetraosylceramide (asialo GM1) and gangliotriaosylceramide (asialo GM2). Arch Biochem Biophys 1988, 260:493-496.
27. de Bentzmann S., Roger P., Dupuit F., Bajolet-Laudinat O., Fuchey C., Plotkowski M.C., et al. Asialo GM1 is a receptor for Pseudomonas aeruginosa adherence to regenerating respiratory epithelial cells. Infect Immun 1996, 64:1582-1588.
28. Comolli J.C., Waite L.L., Mostov K.E., Engel J.N. Pili binding to asialo-GM1 on epithelial cells can mediate cytotoxicity or bacterial internalization by Pseudomonas aeruginosa. Infect Immun 1999, 67:3207-3214.
29. Soong G., Reddy B., Sokol S., Adamo R., Prince A. TLR2 is mobilized into an apical lipid raft receptor complex to signal infection in airway epithelial cells. J Clin Invest 2004, 113:1482-1489.
30. Schroeder T.H., Zaidi T., Pier G.B. Lack of adherence of clinical isolates of Pseudomonas aeruginosa to asialo-GM(1) on epithelial cells. Infect Immun 2001, 69:719-729.
31. Wright C, Herbert G, Pilkington R, Callaghan M, McCleanlean S. Real-time PCR method for the quantification of Burkholderia cepacia complex attached to lung epithelial cells and inhibition of that attachment. Lett Appl Microbiol 50, 500-506.
32. Bruscia E., Sangiuolo F., Sinibaldi P., Goncz K.K., Novelli G., Gruenert D.C. Isolation of CF cell lines corrected at DeltaF508-CFTR locus by SFHR-mediated targeting. Gene Ther 2002, 9:683-685.